Accolade (ACCD) Stock Forecast, Price Target & Predictions
ACCD Stock Forecast
Accolade stock forecast is as follows: an average price target of $14.81 (represents a 370.16% upside from ACCD’s last price of $3.15) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.
ACCD Price Target
ACCD Analyst Ratings
Accolade Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 28, 2024 | David Grossman | Stifel Nicolaus | $8.00 | $3.58 | 123.46% | 153.97% |
Jun 28, 2024 | Richard Close | Canaccord Genuity | $13.00 | $6.39 | 103.44% | 312.70% |
Jun 28, 2024 | Ryan MacDonald | Needham | $8.00 | $6.39 | 25.20% | 153.97% |
Jun 28, 2024 | Jailendra Singh | Truist Financial | $9.00 | $6.39 | 40.85% | 185.71% |
Jun 28, 2024 | Stephanie Davis | Barclays | $5.50 | $6.39 | -13.93% | 74.60% |
Jun 28, 2024 | Gil Luria | D.A. Davidson | $5.00 | $6.39 | -21.75% | 58.73% |
Apr 30, 2024 | Stan Berenshteyn | Wells Fargo | $10.00 | $8.19 | 22.10% | 217.46% |
Oct 04, 2023 | Ricky Goldwasser | Morgan Stanley | $14.00 | $10.03 | 39.58% | 344.44% |
Jun 30, 2023 | Ryan MacDonald | Needham | $17.00 | $13.61 | 24.91% | 439.68% |
Jun 30, 2023 | Ryan MacDonald | Needham | $14.27 | $12.64 | 12.90% | 353.02% |
Accolade Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 7 |
Avg Price Target | - | - | $8.36 |
Last Closing Price | $3.15 | $3.15 | $3.15 |
Upside/Downside | -100.00% | -100.00% | 165.40% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 09, 2024 | Stephens | Buy | Buy | Hold |
Oct 04, 2024 | Needham | Buy | Buy | Hold |
Oct 04, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Oct 04, 2024 | Raymond James | Outperform | Outperform | Hold |
Jun 28, 2024 | Canaccord Genuity | Buy | Buy | Hold |
Jun 28, 2024 | Needham | Buy | Buy | Hold |
Jun 28, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Apr 30, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Feb 26, 2024 | Raymond James | Underperform | Underperform | Hold |
Feb 26, 2024 | Wells Fargo | Buy | Buy | Hold |
Accolade Financial Forecast
Accolade Revenue Forecast
Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $96.86M | $93.23M | - | - | $87.64M | $85.53M | - | - | $73.29M | $59.53M | - | - | $36.79M | $35.89M |
Avg Forecast | $174.46M | $136.69M | $133.68M | $136.88M | $160.37M | $121.94M | $120.52M | $121.70M | $142.39M | $106.00M | $104.87M | $105.95M | $123.91M | $96.16M | $94.09M | $90.82M | $99.44M | $87.53M | $82.86M | $81.98M | $91.58M | $75.89M | $70.37M | $55.67M | $56.64M | $36.25M | $34.62M | $34.14M |
High Forecast | $177.47M | $139.05M | $135.98M | $139.24M | $163.13M | $124.04M | $122.60M | $123.80M | $145.27M | $106.80M | $104.95M | $106.32M | $123.91M | $96.64M | $95.71M | $92.39M | $101.16M | $89.04M | $84.54M | $83.64M | $93.44M | $77.43M | $71.80M | $56.80M | $57.79M | $36.99M | $35.33M | $34.83M |
Low Forecast | $169.49M | $132.80M | $129.87M | $132.98M | $155.81M | $118.47M | $117.09M | $118.24M | $136.98M | $105.37M | $104.78M | $105.59M | $123.91M | $95.39M | $91.41M | $88.24M | $96.61M | $85.04M | $80.91M | $80.05M | $89.42M | $74.10M | $68.71M | $54.36M | $55.30M | $35.40M | $33.81M | $33.33M |
# Analysts | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 7 | 9 | 9 | 4 | 5 | 9 | 10 | 5 | 5 | 8 | 4 | 4 | 4 | 7 | 5 | 5 | 5 | 8 | 5 | 5 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.03% | - | - | 1.06% | 1.04% | - | - | 1.04% | 1.07% | - | - | 1.06% | 1.05% |
Accolade EBITDA Forecast
Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 7 | 9 | 9 | 4 | 5 | 9 | 10 | 5 | 5 | 8 | 4 | 4 | 4 | 7 | 5 | 5 | 5 | 8 | 5 | 5 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-20.38M | $-25.94M | - | - | $-34.47M | $-34.81M | - | - | $-63.41M | $-39.37M | - | - | $-10.96M | $-10.71M |
Avg Forecast | $-20.68M | $-16.20M | $-15.85M | $-16.23M | $-19.01M | $-14.45M | $-14.29M | $-14.43M | $-16.88M | $-12.56M | $-12.43M | $-12.56M | $-14.20M | $-11.40M | $-11.15M | $-10.77M | $-12.91M | $-10.38M | $-9.82M | $-9.72M | $-11.73M | $-9.00M | $-8.34M | $-25.75M | $-6.71M | $-4.30M | $-9.04M | $-4.05M |
High Forecast | $-20.09M | $-15.74M | $-15.40M | $-15.76M | $-18.47M | $-14.04M | $-13.88M | $-14.02M | $-16.24M | $-12.49M | $-12.42M | $-12.52M | $-11.36M | $-11.31M | $-10.84M | $-10.46M | $-10.32M | $-10.08M | $-9.59M | $-9.49M | $-9.39M | $-8.78M | $-8.15M | $-20.60M | $-6.56M | $-4.20M | $-7.23M | $-3.95M |
Low Forecast | $-21.04M | $-16.48M | $-16.12M | $-16.51M | $-19.34M | $-14.70M | $-14.53M | $-14.68M | $-17.22M | $-12.66M | $-12.44M | $-12.60M | $-17.04M | $-11.46M | $-11.35M | $-10.95M | $-15.49M | $-10.56M | $-10.02M | $-9.91M | $-14.08M | $-9.18M | $-8.51M | $-30.90M | $-6.85M | $-4.38M | $-10.85M | $-4.13M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.83% | 2.41% | - | - | 3.51% | 3.58% | - | - | 7.60% | 1.53% | - | - | 1.21% | 2.65% |
Accolade Net Income Forecast
Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 7 | 9 | 9 | 4 | 5 | 9 | 10 | 5 | 5 | 8 | 4 | 4 | 4 | 7 | 5 | 5 | 5 | 8 | 5 | 5 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-32.83M | $-38.23M | - | - | $-46.52M | $-342.82M | - | - | $-62.36M | $-48.71M | - | - | $-15.37M | $-13.96M |
Avg Forecast | $6.14M | $-19.48M | $-22.15M | $-25.62M | $6.91M | $-22.42M | $-23.72M | $-26.12M | $2.96M | $-26.42M | $-35.49M | $-38.43M | $-26.83M | $-35.80M | $-43.18M | $-49.44M | $-24.39M | $53.89M | $-57.56M | $-59.10M | $-22.17M | $-62.30M | $-47.15M | $-31.86M | $-7.34M | $-26.69M | $-12.68M | $-29.43M |
High Forecast | $6.28M | $-18.76M | $-21.33M | $-24.68M | $7.06M | $-21.59M | $-22.84M | $-25.16M | $7.10M | $-22.16M | $-34.18M | $-37.01M | $-21.46M | $-28.80M | $-41.59M | $-47.61M | $-19.51M | $64.67M | $-55.80M | $-57.29M | $-17.74M | $-60.39M | $-45.71M | $-25.49M | $-7.12M | $-25.87M | $-10.14M | $-28.53M |
Low Forecast | $5.91M | $-19.92M | $-22.65M | $-26.20M | $6.65M | $-22.92M | $-24.25M | $-26.71M | $-1.77M | $-29.83M | $-36.28M | $-39.30M | $-32.20M | $-40.47M | $-44.15M | $-50.55M | $-29.27M | $43.11M | $-59.08M | $-60.66M | $-26.61M | $-63.94M | $-48.40M | $-38.23M | $-7.53M | $-27.40M | $-15.22M | $-30.20M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 0.77% | - | - | 0.81% | 5.80% | - | - | 1.32% | 1.53% | - | - | 1.21% | 0.47% |
Accolade SG&A Forecast
Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 7 | 9 | 9 | 4 | 5 | 9 | 10 | 5 | 5 | 8 | 4 | 4 | 4 | 7 | 5 | 5 | 5 | 8 | 5 | 5 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $40.34M | $41.11M | - | - | $45.96M | $45.85M | - | - | $50.18M | $46.97M | - | - | $14.33M | $12.98M |
Avg Forecast | $79.74M | $62.48M | $61.10M | $62.56M | $73.30M | $55.73M | $55.08M | $55.63M | $65.08M | $48.45M | $47.93M | $48.43M | $41.23M | $43.95M | $43.00M | $41.51M | $37.48M | $40.01M | $37.87M | $37.47M | $34.07M | $34.69M | $32.16M | $30.72M | $25.89M | $16.57M | $11.83M | $15.60M |
High Forecast | $81.11M | $63.55M | $62.15M | $63.64M | $74.56M | $56.69M | $56.04M | $56.59M | $66.40M | $48.81M | $47.97M | $48.60M | $49.47M | $44.17M | $43.75M | $42.23M | $44.98M | $40.70M | $38.64M | $38.23M | $40.89M | $35.39M | $32.82M | $36.87M | $26.41M | $16.90M | $14.19M | $15.92M |
Low Forecast | $77.47M | $60.70M | $59.36M | $60.78M | $71.21M | $54.15M | $53.52M | $54.04M | $62.61M | $48.16M | $47.89M | $48.26M | $32.98M | $43.60M | $41.78M | $40.33M | $29.98M | $38.87M | $36.98M | $36.59M | $27.26M | $33.87M | $31.41M | $24.58M | $25.28M | $16.18M | $9.46M | $15.24M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 0.99% | - | - | 1.21% | 1.22% | - | - | 1.56% | 1.53% | - | - | 1.21% | 0.83% |
Accolade EPS Forecast
Mar 27 | Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | Aug 20 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 7 | 9 | 9 | 4 | 5 | 9 | 10 | 5 | 5 | 8 | 4 | 4 | 4 | 7 | 5 | 5 | 5 | 8 | 5 | 5 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.43 | $-0.52 | - | - | $-0.66 | $-4.92 | - | - | $-0.97 | $-0.84 | - | - | $-0.47 | $-0.30 |
Avg Forecast | $0.08 | $-0.24 | $-0.28 | $-0.32 | $0.09 | $-0.28 | $-0.30 | $-0.33 | $0.04 | $-0.33 | $-0.44 | $-0.48 | $-0.11 | $-0.45 | $-0.54 | $-0.62 | $-0.41 | $-0.62 | $-0.72 | $-0.74 | $-0.42 | $-0.78 | $-0.59 | $-0.35 | $-0.09 | $-0.33 | $-0.40 | $-0.37 |
High Forecast | $0.08 | $-0.23 | $-0.27 | $-0.31 | $0.09 | $-0.27 | $-0.29 | $-0.31 | $0.09 | $-0.28 | $-0.43 | $-0.46 | $-0.11 | $-0.36 | $-0.52 | $-0.59 | $-0.40 | $-0.60 | $-0.70 | $-0.72 | $-0.41 | $-0.75 | $-0.57 | $-0.34 | $-0.09 | $-0.32 | $-0.39 | $-0.36 |
Low Forecast | $0.07 | $-0.25 | $-0.28 | $-0.33 | $0.08 | $-0.29 | $-0.30 | $-0.33 | $-0.02 | $-0.37 | $-0.45 | $-0.49 | $-0.12 | $-0.51 | $-0.55 | $-0.63 | $-0.42 | $-0.63 | $-0.74 | $-0.76 | $-0.43 | $-0.80 | $-0.60 | $-0.36 | $-0.09 | $-0.34 | $-0.41 | $-0.38 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 0.84% | - | - | 0.92% | 6.67% | - | - | 1.65% | 2.39% | - | - | 1.17% | 0.81% |
Accolade Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ACCD | Accolade | $3.15 | $14.81 | 370.16% | Buy |
HCAT | Health Catalyst | $7.68 | $29.25 | 280.86% | Buy |
DH | Definitive Healthcare | $4.08 | $9.50 | 132.84% | Hold |
CERT | Certara | $10.25 | $20.60 | 100.98% | Buy |
PHR | Phreesia | $18.46 | $36.31 | 96.70% | Buy |
EVH | Evolent Health | $23.36 | $43.00 | 84.08% | Buy |
PRVA | Privia Health Group | $19.22 | $33.82 | 75.96% | Buy |
PINC | Premier | $20.01 | $33.25 | 66.17% | Hold |
CMAX | CareMax | $1.97 | $2.60 | 31.98% | Hold |
HSTM | HealthStream | $29.17 | $29.00 | -0.58% | Buy |
ACCD Forecast FAQ
Is Accolade a good buy?
Yes, according to 16 Wall Street analysts, Accolade (ACCD) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 62.50% of ACCD's total ratings.
What is ACCD's price target?
Accolade (ACCD) average price target is $14.81 with a range of $5 to $52, implying a 370.16% from its last price of $3.15. The data is based on 16 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Accolade stock go up soon?
According to Wall Street analysts' prediction for ACCD stock, the company can go up by 370.16% (from the last price of $3.15 to the average price target of $14.81), up by 1550.79% based on the highest stock price target, and up by 58.73% based on the lowest stock price target.
Can Accolade stock reach $5?
ACCD's average twelve months analyst stock price target of $14.81 supports the claim that Accolade can reach $5 in the near future.
Did the ACCD's actual financial results beat the analysts' financial forecasts?
In terms of the last quarterly report (Aug 2023), Accolade's revenue was $96.86M, beating the average analysts' forecast of $94.09M by 2.95%. The company's EBITDA was $-20.377M, beating the average prediction of $-11.153M by 82.71%. Accolade's net income was $-32.825M, missing the average estimation of $-43.182M by -23.98%. The company's SG&A was $40.34M, missing the average forecast of $43M by -6.20%. Lastly, the company's EPS was $-0.43, missing the average prediction of $-0.539 by -20.27%